HUMBOLDT — Over 1,000 Pfizer-BioNTech doses were given in Humboldt last week as part of the Phase One vaccine rollout.
The Pfizer-BioNTech inoculation is a mRNA vaccine, which works by teaching the body’s cells how to make a protein that will trigger an immune response without using the live virus that causes COVID-19. Once triggered, the body makes antibodies which help fight the infection should it occur.
Phase One of the provincial vaccination plan includes long-term care and personal care home residents as well as prioritized healthcare workers.
All doses in Humboldt were used as the first of two inoculations against the virus. The second doses are scheduled for mid-March.
The Phase One rollout began in January, and focuses on providing the vaccines to priority groups as supply becomes available.
Phase Two of the delivery will focus on the general population in 10-year increments, starting with ages 60 to 69. It is set to be started throughout the province at the earliest in April, depending on vaccine supplies.
